These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21443940)

  • 1. Longer action means better drug: tuning up protein therapeutics.
    Szlachcic A; Zakrzewska M; Otlewski J
    Biotechnol Adv; 2011; 29(4):436-41. PubMed ID: 21443940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to current and future protein therapeutics: a protein engineering perspective.
    Carter PJ
    Exp Cell Res; 2011 May; 317(9):1261-9. PubMed ID: 21371474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology.
    Huang C
    Curr Opin Biotechnol; 2009 Dec; 20(6):692-9. PubMed ID: 19889530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered protein scaffolds as next-generation antibody therapeutics.
    Gebauer M; Skerra A
    Curr Opin Chem Biol; 2009 Jun; 13(3):245-55. PubMed ID: 19501012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of next-generation protein therapeutics.
    Caravella J; Lugovskoy A
    Curr Opin Chem Biol; 2010 Aug; 14(4):520-8. PubMed ID: 20638324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion-proteins as biopharmaceuticals--applications and challenges.
    Schmidt SR
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):284-95. PubMed ID: 19333874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational and "irrational" design of proteins and their use in biotechnology.
    Nixon AE; Firestine SM
    IUBMB Life; 2000 Mar; 49(3):181-7. PubMed ID: 10868908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies towards a longer acting factor VIII.
    Saenko EL; Pipe SW
    Haemophilia; 2006 Jul; 12 Suppl 3():42-51. PubMed ID: 16683996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug development: longer-lived proteins.
    Kontos S; Hubbell JA
    Chem Soc Rev; 2012 Apr; 41(7):2686-95. PubMed ID: 22310725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokaryotic gene fusion expression systems and their use in structural and functional studies of proteins.
    Sheibani N
    Prep Biochem Biotechnol; 1999 Feb; 29(1):77-90. PubMed ID: 10069435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulating protein therapeutics into particulate forms.
    Yang S; Yuan W; Jin T
    Expert Opin Drug Deliv; 2009 Oct; 6(10):1123-33. PubMed ID: 19663629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific polymer modification of therapeutic proteins.
    Kochendoerfer GG
    Curr Opin Chem Biol; 2005 Dec; 9(6):555-60. PubMed ID: 16233987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of protein therapeutics.
    De Groot AS; Scott DW
    Trends Immunol; 2007 Nov; 28(11):482-90. PubMed ID: 17964218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic peptides: technological advances driving peptides into development.
    Sato AK; Viswanathan M; Kent RB; Wood CR
    Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
    Kolmar H
    FEBS J; 2008 Jun; 275(11):2684-90. PubMed ID: 18435757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.